Vor Biopharma Dirección
Dirección controles de criterios 3/4
El CEO de Vor Biopharma es Robert Ang , nombrado en Aug 2019, tiene una permanencia de 5.25 años. compensación anual total es $2.69M, compuesta por 22.5% salario y 77.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.86% de las acciones de la empresa, por valor de $474.55K. La antigüedad media del equipo directivo y de la junta directiva es de 2.1 años y 4.3 años, respectivamente.
Información clave
Robert Ang
Chief Executive Officer (CEO)
US$2.7m
Compensación total
| Porcentaje del salario del CEO | 22.5% |
| Permanencia del CEO | 5.3yrs |
| Participación del CEO | 0.9% |
| Permanencia media de la dirección | 2.1yrs |
| Promedio de permanencia en la Junta Directiva | 4.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Vor Biopharma (NASDAQ:VOR) Will Have To Spend Its Cash Wisely
Sep 10
We're A Little Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate
May 24Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
Dec 05Will Vor Biopharma (NASDAQ:VOR) Spend Its Cash Wisely?
Aug 18Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
May 05Is Vor Biopharma Inc. (NASDAQ:VOR) Trading At A 49% Discount?
Mar 13We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully
Oct 19Vor Bio appoints Eyal C. Attar as chief medical officer
Oct 12Is Vor Biopharma (NASDAQ:VOR) In A Good Position To Invest In Growth?
Jun 18Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
Mar 05Vor Biopharma (NASDAQ:VOR) Is In A Good Position To Deliver On Growth Plans
Aug 30Vor Biopharma: Targeted Therapies For Transplants
Jun 30We're Not Very Worried About Vor Biopharma's (NASDAQ:VOR) Cash Burn Rate
May 10Vor Biopharma EPS misses by $0.03
May 06Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$112m |
| Jun 30 2024 | n/a | n/a | -US$118m |
| Mar 31 2024 | n/a | n/a | -US$120m |
| Dec 31 2023 | US$3m | US$606k | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$116m |
| Jun 30 2023 | n/a | n/a | -US$106m |
| Mar 31 2023 | n/a | n/a | -US$98m |
| Dec 31 2022 | US$5m | US$570k | -US$92m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$81m |
| Mar 31 2022 | n/a | n/a | -US$78m |
| Dec 31 2021 | US$2m | US$508k | -US$70m |
| Sep 30 2021 | n/a | n/a | -US$70m |
| Jun 30 2021 | n/a | n/a | -US$65m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$3m | US$424k | -US$49m |
Compensación vs. Mercado: La compensación total de Robert($USD2.69M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD647.72K).
Compensación vs. Ingresos: La compensación de Robert ha sido consistente con los resultados de la empresa en el último año.
CEO
Robert Ang (49 yo)
5.3yrs
Permanencia
US$2,691,044
Compensación
Dr. Robert Ang, MBBS, MBA, M.D., serves as Independent Non-Executive Director at Enara Bio Limited since September 2021 and serves as its Chairman since August 2024. He is the President, Chief Executive Of...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.3yrs | US$2.69m | 0.86% $ 474.6k | |
| Chief Scientific Officer | 4yrs | US$1.31m | 0.14% $ 79.5k | |
| Chief Medical Officer | 2.1yrs | US$1.40m | 0.015% $ 8.3k | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Interim Principal Accounting Officer | less than a year | sin datos | 0.042% $ 23.0k | |
| Chief People Officer | 4.9yrs | sin datos | sin datos | |
| Chief Commercial Officer & Head of Business Development | 4.3yrs | sin datos | sin datos | |
| Senior Vice President of Portfolio Strategy & Program Management | 1.1yrs | sin datos | sin datos | |
| Senior VP & Head of Quality | 1.1yrs | sin datos | sin datos |
2.1yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de VOR se considera experimentado (2.1 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 5.3yrs | US$2.69m | 0.86% $ 474.6k | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 4.3yrs | US$151.60k | 0% $ 0 | |
| Independent Chairman of the Board | 4.1yrs | US$185.60k | 0.0088% $ 4.8k | |
| Independent Director | 5.8yrs | US$157.50k | 0% $ 0 | |
| Scientific & Clinical Advisor | no data | sin datos | sin datos | |
| Independent Director | 5.7yrs | US$152.10k | 0.043% $ 23.5k | |
| Independent Director | 4.3yrs | US$164.10k | sin datos | |
| Scientific & Clinical Advisor | no data | sin datos | sin datos | |
| Scientific & Clinical Advisor | no data | sin datos | sin datos | |
| Scientific & Clinical Advisor | no data | sin datos | sin datos | |
| Scientific & Clinical Advisor | 3.8yrs | sin datos | sin datos |
4.3yrs
Permanencia media
53yo
Promedio de edad
Junta con experiencia: La junta directiva de VOR se considera experimentada (4.3 años de antigüedad promedio).